| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9959800 | Journal of the American College of Cardiology | 2005 | 6 Pages |
Abstract
There was a statistical interaction between treatment and aspirin in the LIFE study, with significantly greater reductions for the CEP and MI with losartan in patients using aspirin than in patients not using aspirin at baseline. Further studies are needed to clarify whether this represents a pharmacologic interaction or a selection by aspirin use of patients more likely to respond to losartan treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Eigil MD, PhD, Andreas MD, PhD, Sverre E. MD, PhD, Richard B. (FACC), Stevo MD, ScD, Steven M. PhD, Jonathan M. MD, Ulf MD, PhD, Frej MD, PhD, Hans MD, PhD, Krister PhD, Ole MD, PhD, Lars H. MD, PhD, Markku S. (FACC), Per MD, PhD, Suzanne (FACC),